Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Osteoclast differentiation	6/127	2.676173433294478e-09	2.6226499646285886e-07	98.51652892561984	-292.7975978962654	MAP3K7;NFKB1;SPI1;TAB1;TAB2;TGFB1
KEGG_2021_Human	MAPK signaling pathway	7/294	8.613842285651333e-09	4.2207827199691533e-07	63.260162601626014	-208.07497507114164	FLNA;FLNC;MAP3K7;NFKB1;TAB1;TAB2;TGFB1
KEGG_2021_Human	Leishmaniasis	5/77	1.6754970109672824e-08	5.473290235826456e-07	111.05555555555556	-285.8634456707051	MAP3K7;NFKB1;TAB1;TAB2;TGFB1
KEGG_2021_Human	Toxoplasmosis	5/112	1.1171098780714114e-07	2.7369192012749584e-06	74.40186915887851	-210.55667833010622	MAP3K7;NFKB1;TAB1;TAB2;TGFB1
KEGG_2021_Human	Salmonella infection	6/249	1.5298853524997396e-07	2.9985752908994896e-06	48.30246913580247	-163.50255926584217	FLNA;FLNC;MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Hepatitis B	5/162	7.08729574350555e-07	1.1575916381059065e-05	50.388535031847134	-153.38399251928269	MAP3K7;NFKB1;TAB1;TAB2;TGFB1
KEGG_2021_Human	NF-kappa B signaling pathway	4/104	5.130876847568527e-06	6.285324138271445e-05	53.12	-132.3420645012429	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Toll-like receptor signaling pathway	4/104	5.130876847568527e-06	6.285324138271445e-05	53.12	-132.3420645012429	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	TNF signaling pathway	4/112	6.897261761044327e-06	7.510351695359377e-05	49.135802469135804	-124.17448810278691	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	0.00015056463578908802	39.774436090225564	-104.03256013781805	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	NOD-like receptor signaling pathway	4/181	4.608088790455273e-05	0.00041053881951328797	29.721280602636536	-80.60331713278154	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.0005244544379840654	27.202072538860104	-74.37625984844887	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Epstein-Barr virus infection	4/202	7.083103438365334e-05	0.0005339570284306175	26.4983164983165	-72.60755777125968	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Lipid and atherosclerosis	4/215	9.035438443106581e-05	0.0005903153116162966	24.824644549763033	-68.34725873383007	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Human immunodeficiency virus 1 infection	4/212	8.553680416035766e-05	0.0005903153116162966	25.192307692307693	-69.28980198257669	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0009341909684997769	21.55922865013774	-59.801482853342776	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	IL-17 signaling pathway	3/94	0.00017260861398757182	0.0009950378923989434	37.56828885400314	-73.71479219141467	MAP3K7;NFKB1;TAB2
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.002981550739757036	24.99579831932773	-51.672386684351224	MAP3K7;NFKB1;TAB2
KEGG_2021_Human	Proteoglycans in cancer	3/205	0.0016941022902244062	0.008738001286420622	16.68882602545969	-35.25303962280841	FLNA;FLNC;TGFB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.01003728912423417	15.579365079365079	-32.91284230349772	NFKB1;SPI1;TGFB1
KEGG_2021_Human	Herpes simplex virus 1 infection	4/498	0.002222912628244597	0.010373592265141453	10.22132253711201	-27.191293900864785	MAP3K7;NFKB1;TAB1;TAB2
KEGG_2021_Human	Coronavirus disease	3/232	0.0024164136009215383	0.010764024222286853	14.670617592014972	-30.966105875434415	MAP3K7;NFKB1;TAB2
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.011726544690631143	31.765873015873016	-40.07734547796954	NFKB1;TGFB1
KEGG_2021_Human	Acute myeloid leukemia	2/67	0.002921615714870147	0.011929930835719766	30.78076923076923	-39.02900444511024	NFKB1;SPI1
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.0031848593502604382	0.012484648653020918	29.41176470588235	-37.553176952571945	MAP3K7;NFKB1
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.013588070060393505	27.006756756756758	-34.90410589940028	NFKB1;TGFB1
KEGG_2021_Human	Pancreatic cancer	2/76	0.0037436519554145367	0.013588070060393505	27.006756756756758	-34.90410589940028	NFKB1;TGFB1
KEGG_2021_Human	Hypertrophic cardiomyopathy	2/90	0.005212350356610659	0.018243226248137307	22.670454545454547	-29.92662218019896	DMD;TGFB1
KEGG_2021_Human	Dilated cardiomyopathy	2/96	0.005911165720442844	0.019975663469082715	21.20744680851064	-28.182173664612183	DMD;TGFB1
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.020368219925688377	19.92	-26.61700675496218	NFKB1;TGFB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.020368219925688377	20.331632653061224	-27.120602948412195	NFKB1;TGFB1
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.020368219925688377	19.92	-26.61700675496218	NFKB1;TGFB1
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.020509913453342285	19.524509803921568	-26.130280011490946	MAP3K7;NFKB1
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.021035675220026653	18.95952380952381	-25.42995427691617	NFKB1;TGFB1
KEGG_2021_Human	Relaxin signaling pathway	2/129	0.010471317399144716	0.029319688717605204	15.631889763779528	-21.1770620526928	NFKB1;TGFB1
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.03289629453277457	14.472627737226277	-19.639406588988233	MAP3K7;NFKB1
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.03884590887020547	12.847402597402597	-17.429441058365175	NFKB1;TGFB1
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.03884590887020547	12.933006535947712	-17.54750234216727	NFKB1;TGFB1
KEGG_2021_Human	Tuberculosis	2/180	0.019755026308062106	0.049640835338207345	11.081460674157304	-14.950240051620256	NFKB1;TGFB1
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.02165639204960556	0.05305816052153362	10.536096256684491	-14.167050995225416	MAP3K7;NFKB1
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.053318922928764376	10.365789473684211	-13.920708621090329	NFKB1;SPI1
KEGG_2021_Human	Focal adhesion	2/201	0.02430775457262447	0.05515247023706872	9.885678391959798	-13.221635183162709	FLNA;FLNC
KEGG_2021_Human	Diabetic cardiomyopathy	2/203	0.024762333575826773	0.05515247023706872	9.784825870646767	-13.073912909097736	NFKB1;TGFB1
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.05515247023706872	6.12012987012987	-11.164029011261546	NFKB1;SPI1;TGFB1
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.10732240488792681	6.6339590443686	-8.300944532041967	GH1;TGFB1
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.1229762416347493	18.962174940898347	-11.032973182262484	TGFB1
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.1229762416347493	18.183673469387756	-10.63265628196324	TGFB1
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.1229762416347493	18.564814814814813	-10.829316375605623	NFKB1
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.13406404562543403	5.480113636363637	-6.479364551821025	GH1;NFKB1
KEGG_2021_Human	Legionellosis	1/57	0.06840002327828267	0.13406404562543403	15.896825396825397	-9.424000900813787	NFKB1
KEGG_2021_Human	Viral myocarditis	1/60	0.07188046794101291	0.13812325212194637	15.08286252354049	-8.981081638876871	DMD
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.0753492056247738	0.14200427213899677	14.347670250896057	-8.574814690072902	NFKB1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.14535326416108088	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.14535326416108088	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.14535326416108088	13.071895424836601	-7.854937277937848	NFKB1
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.14535326416108088	13.071895424836601	-7.854937277937848	TGFB1
KEGG_2021_Human	Adherens junction	1/71	0.08454220466511847	0.14535326416108088	12.695238095238095	-7.638591016595616	MAP3K7
KEGG_2021_Human	Arrhythmogenic right ventricular cardiomyopathy	1/77	0.09138288226635771	0.15178851630683146	11.68421052631579	-7.04872976578505	DMD
KEGG_2021_Human	Pertussis	1/76	0.09024597396088518	0.15178851630683146	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.09591773965141367	0.15666564143064232	11.094444444444445	-6.698191160265787	NFKB1
KEGG_2021_Human	Colorectal cancer	1/86	0.10155766145487406	0.16315821020619112	10.435294117647059	-6.300464747037211	TGFB1
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.16409906629596846	9.632850241545894	-5.8073541800756905	TGFB1
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.16409906629596846	9.739926739926739	-5.8737398650795125	NFKB1
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.16409906629596846	9.528076463560334	-5.7422174156532195	TGFB1
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.16409906629596846	10.075757575757576	-6.080768259179883	NFKB1
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.16409906629596846	9.739926739926739	-5.8737398650795125	NFKB1
KEGG_2021_Human	Prostate cancer	1/97	0.11385418156418702	0.16653298198940789	9.226851851851851	-5.553951626329874	NFKB1
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.17206676876523377	8.764576457645765	-5.262086311101535	NFKB1
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.17270747845664444	8.592233009708737	-5.152341092635986	NFKB1
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.1754277858753117	8.2668743509865	-4.943743954376122	NFKB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.1754277858753117	8.189300411522634	-4.893732148578802	NFKB1
KEGG_2021_Human	AMPK signaling pathway	1/120	0.13907692219429554	0.18172717833387952	7.4220354808590105	-4.393179099544486	MAP3K7
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.18172717833387952	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.18172717833387952	7.4858757062146895	-4.435243302362896	GH1
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.18172717833387952	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Cell cycle	1/124	0.14339691916847833	0.1849065536646168	7.177055103884372	-4.231046804704064	TGFB1
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.1920672636562796	6.7846153846153845	-3.968927686510734	TGFB1
KEGG_2021_Human	Autophagy	1/137	0.15730251033809037	0.19763648734785713	6.480392156862745	-3.763669230249352	MAP3K7
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.20170196842762844	6.2466509062253746	-3.6047270952512624	NFKB1
KEGG_2021_Human	Gastric cancer	1/149	0.16995776547310146	0.20819826270454928	5.945945945945946	-3.3986573195730956	TGFB1
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.21572014769900724	5.635327635327635	-3.183908163692195	NFKB1
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.21785030018705046	5.456866804692892	-3.0596637281364782	GH1
KEGG_2021_Human	Hippo signaling pathway	1/163	0.1845058664849509	0.21785030018705046	5.422496570644719	-3.0356632226338247	TGFB1
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.21865037697674625	5.321885521885521	-2.9652743858654524	MAP3K7
KEGG_2021_Human	Hepatocellular carcinoma	1/168	0.18964573513289215	0.21865037697674625	5.256819693945443	-2.919648521708157	TGFB1
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.2207696339105133	5.131254061078622	-2.8313674486945275	NFKB1
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.23933203710904188	4.55787037037037	-2.4244944960200487	NFKB1
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.23933203710904188	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.24755035578889023	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.25863875995587166	4.058397932816537	-2.065502377074288	NFKB1
KEGG_2021_Human	Human cytomegalovirus infection	1/225	0.24621391857748554	0.26515345077575364	3.890873015873016	-1.9442968935376908	NFKB1
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.2694040717786765	3.7696007696007694	-1.8563524399324505	NFKB1
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.2735068193372692	3.6554621848739495	-1.7734497985532327	NFKB1
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.33777042349261777	2.7900035958288387	-1.143955577607994	NFKB1
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.35285043978653025	2.6053872053872054	-1.0106876845884132	NFKB1
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.357799624676664	2.5254901960784313	-0.9533164047874388	GH1
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.37748896221639233	2.32487922705314	-0.8103995559567543	NFKB1
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	NFKB1
